Portfolio company Quibim received FDA clearance for its prostate lesion-detection imaging AI.
Quibim is a pioneering company focused on transforming healthcare through AI-guided precision solutions, particularly in the field of medical imaging
Quibim is a pioneering company focused on transforming healthcare through AI-guided precision solutions, particularly in the field of medical imaging. They offer a cloud-based platform that extracts key radiomics drivers from imaging data to improve patient outcomes.